Search by Drug Name or NDC
NDC 00781-3416-94 Voriconazole 10 mg/mL Details
Voriconazole 10 mg/mL
Voriconazole is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is VORICONAZOLE.
Product Information
| NDC | 00781-3416 |
|---|---|
| Product ID | 0781-3416_61eee1bb-bffc-4bf6-b3f7-421636e833db |
| Associated GPIs | 11407080002120 |
| GCN Sequence Number | 050444 |
| GCN Sequence Number Description | voriconazole VIAL 200 MG INTRAVEN |
| HIC3 | W3B |
| HIC3 Description | ANTIFUNGAL AGENTS |
| GCN | 17499 |
| HICL Sequence Number | 023720 |
| HICL Sequence Number Description | VORICONAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | Voriconazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Voriconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | VORICONAZOLE |
| Labeler Name | Sandoz Inc |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090862 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00781-3416-94 (00781341694)
| NDC Package Code | 0781-3416-94 |
|---|---|
| Billing NDC | 00781341694 |
| Package | 1 VIAL, SINGLE-USE in 1 CARTON (0781-3416-94) / 20 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2012-05-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |